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ABSTRACT

ARTICLE HISTORY

Aphasia research uses the length of time within rehabilitation
sessions as the main measure of dosage. Few papers detail
therapeutic ingredients or outline the number of times these
were delivered over the treatment period. The present
observational study identiﬁed therapeutic ingredients in the
Very Early Rehabiltiation in SpEech (VERSE) trial and explored
the dosage provided using a model of cumulative
intervention intensity (CII). Therapists video recorded one
therapy session per week and 53 (12%) randomly selected
therapy videos were analysed. The videos were coded for
number of error productions, self-corrections and type and
frequency of therapist cueing. The Western Aphasia Battery
Revised-Aphasia Quotient (WABR-AQ) was used for measuring
patient outcome with total verbal utterances (p < 0.001) and
cues used with success (p < 0.001) being independent positive
predictors of WABR-AQ score at six months post stroke and
hypothesized as key therapeutic ingredients. The CII was
calculated by counting identiﬁed therapeutic ingredients and
multiplying this by the number of sessions completed.
Collectively, the key ingredients occurred on average 504
times per session and over 10,000 times per participant during
the treatment period. This paper reports a novel approach for
identifying key treatment ingredients and detailing the
dosage delivered within an early aphasia rehabilitation trial.
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Introduction
The rehabilitating brain and dosage
Rehabilitation has progressed from a focus on rheumatic diseases in the nineteenth
century, through war time needs, to the present day. More people are surviving
brain injury than ever before, resulting in greater demands placed on rehabilitation
services (van de Sandt-Koenderman et al., 2012). For rehabilitation to be successful,
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the brain relies on complex chemical and neuronal mechanisms to induce permanent adaptation in cognitive processes. Learning is a cognitive process essential to
successful rehabilitation. Behavioural therapy for impairments after a brain lesion do
not aim to provide a cure but to maximize the capacity of the damaged networks to
re-learn with experience and for learning to alter the neural functioning at a synaptic
level (Murphy & Corbett, 2009; Varley, 2011). Identifying the optimal treatment and
its dosage is highly complex given the myriad of factors that may inﬂuence the
eﬀect of treatment (Kamhi, 2012). Important components of the rehabilitation
jigsaw may include dosage, therapeutic relationship, medium of therapy delivery,
client motivation, cognitive ability, neurological stability (Whitworth et al., 2014)
as well as task-speciﬁc practice (Lang et al., 2015). Developing an understanding
of the key elements of therapy needed and the dosage with which these should
be delivered are likely to be an important piece of the rehabilitation jigsaw.
Learning within neurorehabilitation sessions is concerned both with client acts
and inputs from the therapist (Kleim & Jones, 2008). The dosage at which these
are delivered is crucial. Treatment sessions aim to capitalize on and enhance the
brain’s natural inherent plasticity that underpins learning (Crosson et al., 2019). Neurorehabilitation focuses largely on practice dependent learning that occurs when an
individual repeatedly uses a skill to induce lasting neuronal change (Robbins et al.,
2008). This focus is grounded largely in Hebbian learning theory which proposes
learning occurs by connections that develop through inputs that co-occur and
can be summarized by “neurons that ﬁre together wire together” (Hebb, 1949). It
requires repetition to induce lasting cellular changes that add stability to the
network (Pulvermuller & Berthier, 2008). Neuronal assemblies must be repeatedly
active at the same time when forming links (Pulvermuller & Berthier, 2008).
Increased repetition of a newly learned behaviour may be required to induce
lasting neural changes (Kleim & Jones, 2008) and so, in theory, the more frequently
two relevant brain events occur together, the more the critical connections will be
strengthened (Pulvermuller & Berthier, 2008). Assuming that therapy can induce
coincidental learning, it has been hypothesized that more training will help
improve learning and may change behaviour (Pulvermuller & Berthier, 2008). It is
also hypothesized that there is a point of diminishing return to increasing the
amount of therapy and so the dosage associated with a therapeutic “sweet spot”
is yet to be discovered (Yoder et al., 2012). Additionally, there is the term “reaction
range” indicating that the response to therapy varies depending on the individuals
brain functioning (Gottesman, 1963; Yoder et al., 2012). Both of these concepts need
to be considered in neurorehabilitation as increasingly, particularly with aphasia
therapy, intense may not be better (Godecke et al., 2018).
Deﬁning dosage
There is no consensus for a deﬁnition of dosage within the stroke rehabilitation literature. Dosage has been deﬁned as the amount of the active ingredient delivered
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at any one time, the frequency with which the active ingredient is delivered and
time duration or length of time across which the active ingredient needs to be delivered in order to produce the desired eﬀect (Lang et al., 2015). Frequently, in the
stroke rehabilitation literature, the terms intensity and dosage are used interchangeably. There has been a call for consistent distinct terminology as the terms intensity
and dosage have been used to refer to a greater number of therapeutic events
occurring in a shorter amount of time, greater number of hours in therapy
massed or distributed, or a greater number of total hours of therapy (Harnish
et al., 2014). Deﬁnitions of dosage vary in the physical therapy literature with
some deﬁning dose as the amount of time actively spent in practice and others
as the number of repetitions of a movement. However, the concept of repeated episodes of intervention over a period of time is common across the diﬀerent
deﬁnitions of dosage (Baker, 2012). In a meta-analysis of dose–response relationships in stroke rehabilitation, the dosage measure of therapy time was used as
this was the most consistently reported measure in studies (Lohse et al., 2014).
The authors acknowledged that ideally active time in movement practice or movement repetitions would be reported and used in subsequent meta-analyses.
Although the measurement of limb movements or repetitions is diﬀerent to the
measurement of repetition in language based activities, the same challenges associated with measuring dosage are present. This paper uses the deﬁnitions of dose and
intensity outlined by Warren et al. (2007) which is explained further. Regardless of
how dosage is deﬁned, increasing the dose of rehabilitation interventions is a
major challenge for therapists (Vratsistas-Curto et al., 2019). Computerized or technology-based therapies have the potential to support increasing the dose of therapy
as patients may practice independent of the therapist and be set dose targets to
attain. There may be additional beneﬁts to computerized therapies such as obtaining data on dose and practice ﬁdelity without relying on therapist report or monitoring therapist participant interactions.
Measuring dosage
The measurement of dosage is complex in behavioural interventions however
needs to be considered in planning and monitoring interventions. In planning
an intervention it is not only important for researchers to specify a therapy type
but also whether an intended level of dosage (amount in the session) is a key component of the therapy. In the implementation of the intervention the level of
dosage provided should be measured and then reported within publications.
These processes are needed in order to develop a greater understanding of the
impact of the dosage within the interventions being trialled. Despite the complexity in measuring dosage it is vitally important to make sure the minimum required
dosage level is planned for and achieved in treatment eﬃcacy research. Specifying
dosage will allow for improved treatment ﬁdelity, facilitate the completion of replication studies and better therapy delivery to patients (Harnish et al., 2014). As an
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example, Bakheit et al. (2007) reported that only thirteen of the ﬁfty one participants received the intensive aphasia intervention as planned. The study cited
that it was likely the amount of therapy received by the intensive therapy group
was below the threshold that is required to signiﬁcantly enhance recovery of
language function (Bakheit et al., 2007; Robey, 1998).
A formula for dosage
While it is acknowledged that is important to measure the dosage of an intervention, a deﬁnition of dosage and a method of measuring dose is not yet well
accepted. Warren et al. (2007) called for behavioural scientists to adopt a
similar approach to the pharmacological studies and investigate therapeutic
eﬀects for diﬀerent dosage levels. They proposed a comprehensive model of
intervention intensity and this was adapted and applied by Baker (2012). The
model provides a method of determining the dose of a treatment, or the Cumulative Intervention Intensity (CII), across an intervention period by ﬁrst considering the task in which the teaching episode takes place. In the CII formula the
focus is shifted from session duration to the number of times an ingredient
occurs per session. Session duration in minutes is only considered when measuring a dose rate (Dose/session duration (mins)). The concept has been praised for
encouraging researchers to develop a quantitative model of interactive factors to
describe a treatment approach. Figure 1 outlines Baker’s (2012) application of
Warren et al. (2007) dosage concepts visually.
Parameters involved in determining the optimal intensity of intervention,
based on Warren et al. (2007).
The application of most of these parameters appears straight forward for
aphasia research. However, even the simplest treatments are multifaceted
(Warren et al., 2007) and identifying the teaching episodes that contain the
active ingredients is the most diﬃcult aspect of implementation. It is unclear
which factors contribute to cumulative intervention intensity and whether these
will inﬂuence treatment outcome in aphasia (Crosson et al., 2019). Even a
picture naming task in therapy involves many cognitive processes that could
contain a number of active ingredients such as the cueing or feedback used by
the therapist, and whether the task is at the correct challenge point for the
people with aphasia (PWA). There is the additional complexity of whether the
accuracy of production counts or discounts a teaching episode. For example, an
error made during stimulus production may exclude that attempt in the dosage
calculation, depending on the underlying theory of the treatment. Warren et al.
(2007) suggest that this is one of the beneﬁts of the model in that it requires clinicians and researchers to think about and specify what their active ingredients are
as well as the theory underpinning them. More broadly, researchers need to consider whether interventions could be examined to identify the active ingredient/s
in order to measure these and prescribe a dose (Baker, 2012).
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Figure 1. Reproduced with permission from Baker (2012).

Active ingredients in aphasia therapy
Behavioural interventions are thought to have one or more active ingredients.
Articles about complex treatments often don’t provide information on active
ingredients (Behn et al., 2019; Ludemann et al., 2017; Yamato et al., 2016) or
their corresponding dosage because it hasn’t been investigated, possibly due
to the challenges associated with measuring these components (Cherney,
2012). Aphasia and other complex interventions can be viewed as a “black
box” containing therapeutic inputs and clients’ outputs with little understanding
of how the components of therapy work. Dissecting the “black box” of treatments, in order to identify the active ingredients and explain how they work,
is a challenge for researchers and practitioners. One explanation for why we
lack more detailed understandings of therapies is that rehabilitation practice is
frequently not theory driven (Dijkers et al., 2014). If researchers were able to disaggregate interventions to test theory driven hypotheses about potential active
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ingredients we may have more knowledge about the individual and joint eﬀects
of our treatments not just whether they work or not (Dijkers et al., 2014).
When the targeted goals are complex, deﬁning teaching episodes becomes
very challenging (Hoﬀman, 2009). Baker (2012) has highlighted that dosage can
only be determined accurately when active ingredients within teaching episodes
have been identiﬁed. In doing this it is important to consider how the underlying
theory is applied in the development of the treatment. For example, neuroplasticity principles state that accurate, error-free practice of a skill is beneﬁcial for rehabilitation outcomes (Biernaskie & Corbett, 2001; Nudo, 2013; Raymer et al., 2008).
Therefore, investigations of therapy may focus on the quantity and accuracy of
language produced by PWA. The rationale for examining how much PWA say is
that (a) improvement in therapy is experience dependent and (b) a lack of experience of practice may result in learned non-use (Pulvermuller et al., 2001; Pulvermuller & Berthier, 2008). Therapy should involve practising tasks, involving an
error minimization approach, to avoid a lack of experience causing atrophy in
the network as well avoiding the strengthening of negative neural networks
(Varley, 2011). If recovery depends both on the quantity and accuracy of PWA production then therapist behaviours, including cueing to facilitate successful outputs
from the PWA, together with the PWA’s production or output within therapy, are
key to recovery. This is in line with Baker’s (2012) view that active ingredients can
involve therapeutic inputs or client acts.
Aphasia rehabilitation and dosage
According to the most recent Cochrane review, speech therapy is beneﬁcial for
people with aphasia (Brady et al., 2016). However, there is a dearth of literature
on the optimal intervention intensity and the dose with which intervention
should be delivered (Baker, 2012; Oﬀ et al., 2016). As such, the optimal treatment
regimen in aphasia rehabilitation is unknown (Dignam et al., 2015). Despite the existence of deﬁnitions for intensity and dosage (Baker, 2012; Warren et al., 2007), operational deﬁnitions of treatment intensity and dosage have not been agreed upon
and are not applied consistently within aphasia research. Additionally, when time
in therapy is used as a deﬁnition on treatment intensity and/ or dosage, there is
inconsistency in the description of what constitutes high and low dose therapy provision. For example dosage is described, within the Cochrane review (Brady et al.,
2016), as hours of therapy provided reﬂecting the way in which dosage is most commonly reported in studies in the review. The number of therapy hours in the “high
dose” speech language pathology (SLP) intervention varied from twenty seven
hours up to 208 h whereas “low dose” received ﬁve hours to 78 h. The inconsistency
in terminology presents a challenge for researchers and clinicians.
When intensity has been investigated as a key factor in the outcome of
therapy it is unclear if the impact of therapy is due to the intensity with which
the therapy was provided or what was contained within the therapy (Sage
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et al., 2011). While many aphasia studies, as per the Cochrane review, report
intervention dosage using time, they give little insight into active ingredients
or within session therapy dosage. When Cherney (2012) compared eleven
studies across 195 participants for high and low intensity aphasia they found
that only 3 studies provided information on the dosage level delivered within
the session, or the number of times a teaching episode containing an active
ingredient occurred per session. It is not only that intervention studies are not
reporting optimal intensity, but the dosage of a “typical” aphasia therapy
session is also unknown as benchmarking studies are rarely undertaken
(Enderby, 2012). This means many therapists are therefore unaware of the
dosage they are providing in usual care, or the active ingredients of the
therapy, so it is also important to establish normative data prior to dosage
manipulation (Dignam et al., 2015).
Eﬀorts have been made more recently to specify key therapeutic ingredients and
report the dosage of these within trials. Dignam et al. (2015) provided the cumulative treatment intensity as per Warren et al.’s (2007) model for the treatment delivered in the ﬁrst dosage controlled, parallel-group design study to compare the short
and long term therapeutic outcomes of massed versus distributed comprehensive
aphasia programme in participants with chronic aphasia. Distributed over massed
practice was favoured in which therapy in the distributed arm involved 6 h per week
for 8 weeks days whereas participants in the intensive practice arm received 16 h per
week for 3 weeks. All participants received Aphasia LIFT therapy (Rodriguez et al.,
2013), a combination of impairment, functional, computer based and group
therapy. Over the treatment period the semantic feature analysis component delivered 118.3 teaching episodes and the phonological component analysis delivered
114.3 teaching episodes. This represents a high level of dosage analysis for an
aphasia trial. Another attempt at measuring the dosage of active ingredients is a
case series study from Harnish et al. (2014) who used a targeted cueing programme
for aphasia rehabilitation. Eight participants attempted to name ﬁfty target pictures,
eight times during each session for a total of 400 attempts per session. The reported
cumulative intervention intensity was 3200 teaching episodes and the treatment
resulted in signiﬁcant gains in reacquiring problematic words (Harnish et al.,
2014). This study has been praised for its well-constructed theory driven protocol
that provides the foundation for continued and deliberate dosage investigations
(Oﬀ et al., 2016). It is plausibly easier to conceptualize measuring dosage in single
word treatments as opposed to conversational treatments and this presents a challenge for discourse rehabilitation.
Study aims
This study investigated the dose form and dose frequency (Warren et al., 2007)
provided within the Very Early Rehabilitation in SpEech (VERSE) trial (Godecke
et al., 2016) sessions with the following aims:
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(i) Analyse the dosage level provided within a session for:
a. The two intensive therapy groups (Usual Care-Plus and VERSE)
b. Aphasia severities (mild, moderate and severe)
(ii) Identify key ingredients in the intervention that are correlated with the
primary outcome at 12 and 26 weeks post stroke.
(iii) Calculate the cumulative intervention intensity for both intensive therapy
groups (Usual Care-Plus and VERSE) (Warren et al., 2007).

Method
Very Early Rehabilitation in SpEech (VERSE) Trial
VERSE investigated whether intensive prescribed aphasia therapy (VERSE treatment) and intensive non-prescribed usual care therapy were more eﬀective
and cost saving than non-prescribed usual care training in very early aphasia
recovery after stroke (Godecke et al., 2013). VERSE was a RCT with the interventions oﬀered in the trial as follows:
(i) Usual Care: Participants randomized to this group received care that is
typical for aphasia management and at the discretion of the treating SLP.
It also included management of other speech pathology impairments
such as dysphagia, dysarthria and/or apraxia of speech however only
aphasia speciﬁc hours were included as therapy hours within the primary
study analysis.
(ii) Usual Care-Plus: Participants received treatments typical of direct aphasia
therapy, at the discretion of the treating SLP, but with a deﬁned therapy
regimen of daily (5 days per week) aphasia therapy sessions for 45–60
min duration over 20 sessions. Direct aphasia therapy included 1:1 impairment based therapy, impairment based computer training, social training,
group impairment based therapy, group social training or Augmentative
and Alternative Communication (AAC) training. As the Usual Care-Plus condition in the trial did not include a prescribed treatment type, speciﬁed
active ingredients or dosage schedule, there is a unique opportunity for
measurement of a “typical” aphasia session.
(iii) VERSE intervention: The intensity of this intervention arm matched that of the
Usual Care Plus arm but the intervention was prescribed and standardized
according to a VERSE intervention protocol. As per treatment ﬁdelity recommendations, signiﬁcant consideration was given when planning the prescribed intervention to highlight theoretical underpinnings, allowing these to
be monitored and evaluated. The goal of the VERSE prescribed treatment,
was to facilitate and improve verbal output with therapists using a targeted
cueing hierarchy to promote successful, independent verbal production.
Therapists were instructed to use cues that were most likely to be successful

NEUROPSYCHOLOGICAL REHABILITATION

9

once participants produced an incorrect response. Participants were encouraged to repeat the target for practice in connected speech. The rationale
behind the treatment postulated that correct production of the target as
quickly as possible would strengthen the networks responsible for language
production and that high repetition of output with reduced error production
would lay the foundations for improved language and communication outcomes in early stroke recovery. In this way, cueing was thought to be a
key ingredient as well as the dosage level of error free productions achieved
by the participant in a session.This impairment based intervention was
founded on principles of promoting neuroplasticity through targeted early
intensive language therapy. The main principles that guided the VERSE prescribed intervention were (a) massed practice (b) error-free learning (c) task
complexity (d) salience and (e) maximizing communicative success
through interactive functional tasks.

Participants
Participants were recruited to VERSE if they had aphasia secondary to an acute
intracerebral haemorrhage or ischaemic stroke, were 18 years of age or over,
had corrected hearing and vision, were medically stable at or before 14 days
post stroke and could participate in aphasia therapy in English without the
need for an interpreter. Exclusion criteria included pre-existing aphasia prior to
hospital admission, a history of progressive neurological disease, brain injury,
neurosurgery or major depression, and an inability to maintain alertness for 30
consecutive minutes at 14 days post stroke. Following baseline assessment, participants were randomized using a computer-generated, block randomization
sequence, stratiﬁed for aphasia severity via the REDCAP web-based programme
(Harris et al., 2009). VERSE recruited 246 participants, 81 in usual care, 82 in Usual
Care-Plus and 83 in the VERSE condition (Usual Care-Plus and VERSE conditions
being the intensive conditions). Participants were recruited from sites across Australia and New Zealand and were assessed at baseline, 12 and 26 weeks post
stroke on a range of impairment, psychosocial and economic based measures.
The primary outcome measure and dependent variable for VERSE was the
WAB-AQ (Kertesz, 2006) at 12 weeks post stroke. Please refer to the VERSE protocol paper (Godecke et al., 2016) for full study details. Recruitment was completed in February 2018 and the last patient visit was undertaken in August 2018.
Therapists
In the UC+ and VERSE conditions SLPs were contracted speciﬁcally for the trial
and were qualiﬁed SLPs. All UC, UC+ and VERSE treating SLPs underwent training
(ﬁve hours) and received procedural and training manuals relevant to the arm of
therapy they were providing. Clinical support was provided by the trial Treatment Fidelity Coordinator (VERSE) or trial clinical staﬀ as required.
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Therapy ﬁdelity dosage sub-study
Video recording and randomization
This study examined therapy videos collected from the VERSE and UC+ arms of
the VERSE trial (Godecke et al., 2016). Therapists from the two intensive therapy
arms VERSE and UC+ were required to record four therapy sessions over the 20
sessions completed. Therapists were encouraged to record one session a week.
Of the 246 participants included in the VERSE trial (81 in UC, 82 in UC+ and 83 in
the VERSE condition), 434 therapy videos were recorded (5% of the 8915 therapy
sessions completed in the trial). To be included in the current study videos had to
be at least forty minutes in length and not contain the present author as the
therapist, the participants shown in the video had to have completed the full
treatment protocol and have the 12 and 26 week dependent outcome
measure score, WABR-AQ (Kertesz, 2006) available and the video needed to be
playable on Windows Media Player. A research assistant not involved with the
current project used a computer generated block randomization sample of
videos stratiﬁed for aphasia severity to select therapy videos for all participants.
The sample comprised 53 randomly selected videos representing 12% of the
total recorded sample.
Procedure
Transcription. The selected videos were transferred and stored in a secure cloud
based service. Each therapy video was then transcribed verbatim using transcription conventions as outlined in the Systematic Analysis of Language Transcripts
(SALT) Transcription guidelines and software (Miller, 2008) (available at http://
saltsoftware.com/resources/tranaids). This included segmenting utterances in
Communication Units or C-Units. Each transcription was then coded according
to a pre-determined set of measures that were based on the theoretical construct of the intervention and believed to represent key therapeutic ingredients.
Coding. Word and utterance level codes, related to the aims of this research,
were developed. Of particular note were the number of error free utterances
and utterances containing errors. The investigation of client acts in this study
focused on the quantity and accuracy of speech from PWA and was grounded
in a neuroscience perspective of experience dependent plasticity, learned nonuse and Hebbian theory (Hebb, 1949; Pulvermuller & Berthier, 2008; Varley,
2011). Aphasia treatment approaches are often described as “error full” or
“error free” referring to whether the PWA is encouraged to attempt target attainment irrespective of the error quantity or whether errors are minimized to avoid
strengthening of associated negative neural networks. For this reason the production and management of errors and participant self-correction of errors
was an area of focus within the coding with frequency of errors and self-corrections viewed as potential active ingredients.
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Table 1. Dosage related measures and possible active ingredients.
Measure
Error free utterances
Errors
Non-verbal
responses
Self-Corrections
Cues used with
success*

Deﬁnition
Total number of utterances without an error.
Total number of errors produced.
Responses that are non-verbal (e.g., gestures).
Errors that have been self-corrected prior to intervention from the therapist
The number of times a cue was used by the therapist and the participant responded
correctly following the cue.

Note: *Cues used with success may represent a client act or therapist input. For ease of interpretation, it has been
categorized as a therapist input within this paper.

An error free response was deﬁned as one which was “appropriate and accurate for the context and not corrected or modiﬁed by the therapist”. Frequently, the
stimulus materials were visible in the therapy video and the transcriber was able
to evaluate the response. In the event that the response could not be assessed as
correct by the video reviewer, it was deﬁned as a response that did not receive
correction or negative feedback from the therapist. Error free responses were
coded at the C-unit/ utterance level. Errors were deﬁned as “inaccurate productions at the word or sentence level that required modiﬁcation, correction or
negative feedback from the therapist”. Error responses were marked at the
word level and utterance level and utterances could contain multiple errors. If
an error was corrected by the PWA, without intervention from the therapist, it
was coded as a self-correction with the initial mistake coded as an error. Boundaries of therapy tasks were not always clear and social conversation was often a
target of therapy. Therefore every utterance from the participant within the
therapy session, from the beginning to the end of the session, was coded and
used as a measure of dosage. Table 1 outlines the codes used in transcription.
Transcription analysis
Dose form. The dosage delivered within a session is highly dependent on the
type of therapy task, or dose form (Warren et al., 2007) being used. A task was
judged by the primary author while watching the videos and was deﬁned as
the medium through which therapy was taking place and reﬂective of a
speciﬁc therapy goal. For example, picture naming at the single word level
would reﬂect a task. The same stimuli used in a sequence to generate sentences
would reﬂect a new task. Tasks usually contained stimuli and task explanations
although not always. Most sessions contained multiple tasks and many tasks
were seen multiple times in the therapy videos. The total number of diﬀerent
tasks provides a value for the number of times therapists used a task that was
unique i.e., had not been used by any other therapists in the videos.
Session duration. Dosage is also dependent on the duration, or length of a
session. To calculate the dosage rate of active ingredients (Dose/session duration
(mins)) the session duration is needed (Warren et al., 2007). Session duration was
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controlled for in the VERSE study as sessions had to be greater than forty minutes
in length and twenty sessions were given in total. The session duration for the
speciﬁc 53 videos used in this study is reported. Please note that session duration
and dosage rate are reported however they are not used in the formula for the
CII (dose × dose frequency × total intervention duration).
Dose. Following transcription and coding, calculations were performed by the
SALT software for both the participant and therapist utterances. These were
total number of verbal utterances, mean length of utterance (MLU) in words
and morphemes, total words, words per minute (WPM), utterances per minute
(UPM) and mean turn length in words. In addition, calculations based on the
codes error codes outlined previously were made manually and these formulas
can be seen in Table 2. Counts of the codes and the calculations were entered
into the statistical software programme SPSS (IBM Corp, 2015) together with
demographic data and the WABR-AQ scores at 12 and 26 week post stroke
scores (dependent measures).
Statistical analysis
Descriptive statistics are presented for participant, session number and duration,
recovery and dose form data. A Welch’s t-test for unequal variances with p >
0.001 (as per Bonferroni correction) was performed to establish signiﬁcant diﬀerences in dose. Within VERSE and Usual Care-Plus arms of the VERSE trial sessions
were expected to be at least 45 min long. However as session time was not controlled for exactly, session length usually ranged from 45 to 60 min, longer
therapy sessions would naturally be higher in many measures. These measures
(as per Tables 8 and 9) were adjusted by dividing the total by the session
time. The resulting standardized data was used in the statistical analyses.
Descriptive statistics are presented according to therapeutic group and
Table 2. Formulas used for calculating measures.
Measure
Spontaneous verbal
utterances
Utterance Level Errors
Word Level Errors
% errors self-corrected
Average no. of errors per
utterance
Average no. of utterances
per error
% total words with errors
Total Turns (participant)
Verbal utterances
(participant)
Total number of cues used
% Cues that were successful
Total therapist utterances

Formula
The number of utterances verbally generated spontaneously. e.g., not a repetition
of a model or a gesture. (verbal utterances) – (repetitions + gestures)
Total number of errors that occurred at the utterance level.
Total number of errors that occurred at the word level.
(self-corrections) / (total errors) x 100
(verbal errors) / (verbal utterances)
(verbal utterances) / (verbal errors)
(errors) / (total words) x 100
Total utterances
Total utterances – gestures
Total number of cues used by the therapist.
Percentage of the total number of cues used by the therapist that were successful
in facilitating accurate production.
Total utterances produced by the therapist.
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aphasia severity is in unadjusted raw format to maintain context. An ANOVA was
used for the between group analyses, to examine diﬀerences between therapy
group (UC+ and VERSE) and aphasia severity (mild, moderate, severe). Signiﬁcance set at p < 0.05 for post hoc analyses.
A linear regression was used to explore the relationship between potential
therapy active ingredients, considering and client acts and therapeutic inputs.
A linear regression model was used across both therapy groups (VERSE and
Usual Care-Plus) with the participant’s primary outcome measure, their WABRAQ score at 12 and 26 weeks being the dependent measure. The WABR-AQ
score at 26 weeks was used as we wanted measures to show longer term association with the dependent variable to be suggestive of maintenance. A Bonferroni
correction was used for multiple comparisons according to the number of variables in the analysis and signiﬁcance was set at p < 0.00277. Baseline aphasia
severity as per the WABR-AQ and the overall amount of direct aphasia therapy
was included as predictors in the model to account for these factors. To be identiﬁed as predictive of WABR-AQ score at 26 weeks, measures had to be signiﬁcant
at 26 weeks post stroke, demonstrating longer term association. The identiﬁed
ingredients were used to calculate the cumulative intervention intensity [dose
(client acts and therapist inputs) × dose frequency × total intervention duration]
(Warren et al., 2007).
Reliability
Six videos (one from each of the three aphasia severity groupings in UC+ and
VERSE) were re-coded for inter and intra-rater reliability by another SLP trained
in the coding methods for this study. This comprised 11% of the total sample
in this study. Reliability was established using the intra-class correlation coeﬃcient (ICC) in SPSS (IBM Corp, 2015) with a consistency 2-way mixed eﬀects
model. The ICC was established on the four key coded measures of interest in
the study – error free utterances, total errors made, total self-corrections and
the total number of cues used with success by the therapist. Koo and Li’s
(2016) guidelines for reporting the ICC have been adhered to in the tables
below. As per Table 3, three of the measures had ICCs in excess of 0.90 and therefore, inter-rater reliability is reported as excellent. The self-corrections measure
was lower with ICCs in the range of 0.75–0.90 which remain in the good reliability
range (Koo & Li, 2016). As the ICCs were all in excess of 0.90 as per Table 4, intrareliability is reported excellent.
Table 3. Inter-rater reliability results using ICC calculation.
95% Conﬁdence Interval
Code
Error free
Errors
Self-corrections
Successful Cues

F Test With True Value 0

Intraclass Correlation

Lower Bound

Upper Bound

Value

df1

df2

Sig

.99
.95
.81
.94

.95
.69
.13
.62

.99
.99
.97
.99

273.75
38.37
9.35
30.54

5
5
5
5

5
5
5
5

.000
.001
.014
.001
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Table 4. Intra-rater reliability results using ICC calculation.
95% Conﬁdence Interval
Code

F Test With True Value 0

Intraclass Correlation

Lower Bound

Upper Bound

Value

df1

df2

Sig

.99
.99
.99
.99

.95
.92
.95
.95

.99
.99
.99
.99

281.24
162.17
270.62
300.42

5
5
5
5

5
5
5
5

.000
.000
.000
.000

Error free
Errors
Self-corrections
Successful Cues

Results
Participants
The 53 videos presented therapy sessions of 44 diﬀerent participants. This
comprised 27% of the total number of participants included in the intensive
arms of the trial (UC+ and VERSE, 165 participants). Of the 53 videos selected
through randomization seven participants had two videos in the sample (total
14 videos), one participant had three videos in the sample (total 3 videos) and
the remaining 36 participants had one video each (total 36 videos). This
resulted in the inclusion of 44 diﬀerent participants. Table 5 presents the
demographic details of these participants. Twenty-ﬁve diﬀerent SLPs were
included within the analysed videos.
Session number
Figure 2 displays the most frequently analysed session numbers within this
sample. Session number fourteen, twenty and ﬁve were the most frequently
viewed.
Table 5. Participant demographic and stroke characteristics.
Demographic

Whole group (n = 44)*

Age, Mean (SD)
Female, n (%)
Oxford Stroke Classiﬁcation
Haemorrhagic, n (%)
PACS, n (%)
PoCS, n (%)
TACS, n (%)
Baseline WAB AQ Severity
Mild, n (%)
Moderate, n (%)
Severe, n (%)
Modiﬁed Rankin Scale Score
2 – Slight, n (%)
3 – Moderate, n (%)
4 – Moderate Severe, n (%)
5 – Severe, n (%)
National Institutes of Health Scale Score
Mean (SD)

VERSE (n = 25)

Usual Care-Plus (n = 19)

72.0 (14.8)
19 (43)

75.0 (14.2)
12 (48)

68.0 (14.7)
7 (37)

3 (7)
34 (77)
1 (2)
6 (14)

2 (8)
18 (72)
0 (0)
5 (20)

1 (5)
16 (84)
1 (5)
1 (5)

15 (34)
13 (30)
16 (36)

8 (32)
7 (28)
10 (40)

7 (37)
6 (32)
6 (32)

6 (14)
17 (39)
11 (25)
10 (23)

5 (20)
7 (28)
7 (28)
6 (24)

1 (5)
10 (53)
4 (21)
4 (21)

9.1 (7.1)

9.4 (7.5)

8.7 (6.5)

Note: PACS = partial anterior circulation syndrome; PoCs = posterior circulation infarct; TACs = total anterior circulation infarct. Baseline WAB-AQ Severity Scores = mild (>62.6), moderate (32.3-62.5) and severe (0-32.2).
*53 videos were selected through randomization. Eight participants had more than one video and 36 participants
had one video in the sample. Therefore, 44 diﬀerent participants are included in this sample.
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Figure 2. Frequency data of session number included in the sample.

Recovery
Figure 3 provides an overall context to the recovery of the participants included
in this study. Based on their severity diagnosis at baseline and reassessment at 12
and 26 weeks on the WABR-AQ, participants at each severity level on average
made an improvement in their scores.

Figure 3. Recovery trend on the WABR-AQ based on baseline severity.
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Table 6. Tasks completed in therapy videos.
Whole group (n =
53)

Measure
Total number of tasks across all sessions
Total number of diﬀerent tasks across all
session
Average no. tasks per session
Total number of verbal tasks (%)
Total verbal tasks at single word level (%)
Total verbal tasks at sentence level (%)
Total verbal tasks at conversation level (%)

VERSE (n =
28)

Usual Care – Plus (n =
25)

152
69

56
18

96
51

2.9
113 (74%)
53 (47%)
43 (38%)
17 (15%)

2
48 (85%)
13 (27%)
23 (48%)
12 (25%)

3.8
65 (68%)
40 (61%)
20 (31%)
5 (8%)

Dose form
Table 6 provides a summary of the number of therapy tasks completed
within the sessions shown in the videos according to each therapeutic group
within the trial. A list of all tasks completed in each condition is provided in
Appendix A (Usual Care-Plus) and Appendix B (VERSE).
Session duration
Table 7 provides a summary of session time to provide a context for the
measures reported in the results section.
Dose – all measured ingredients
Session dosage by therapy group
The dose of all client acts is presented in Table 8 as per the diﬀerent therapy arms
in the trial and the group as a whole. The dose of all therapist inputs is presented
in Table 9. The groups were not found to be signiﬁcantly diﬀerent on any of the
measures, using Welch’s t-test for unequal variances with p > 0.001 (as per Bonferroni correction) indicating an equivalent dosage across the diﬀerent types of
intensive treatment.
Session dosage by aphasia severity
Dosage (client acts and therapist inputs) are outlined in Tables 10 and 11 respectively according to aphasia severity at baseline. Signiﬁcant diﬀerences were found
between the mild and moderate aphasia severity groups on the measures of percentage of errors self-corrected and mean length of utterance (words and morphemes). Signiﬁcant diﬀerences between the mild and severe severity group
were seen in measures of spontaneous verbal utterances, non-verbal responses,
self-corrections, percentage of errors self-corrected, mean length of utterance
Table 7. Session duration in minutes.
Mean Session Time (minutes)

Whole Group (n=53)

Usual Care-Plus (n = 25)

VERSE (n=28)

51.9 (7.3)

50.9 (7.8)

52.8 (6.9)
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Table 8. Dosage (Client Acts) Descriptive Statistics.
Measure
Error free utterances*
Mean (SD)
Median (IQR)
Errors*
Mean (SD)
Median (IQR)
Spontaneous verbal utterances*
Mean (SD)
Median (IQR)
Non-verbal responses*
Mean (SD)
Median (IQR)
Self-Corrections*
Mean (SD)
Median (IQR)
% errors self-corrected
Mean (SD)
Median (IQR)
MLU (words)
Mean (SD)
Median (IQR)
MLU (morphemes)
Mean (SD)
Median (IQR)
Total turns*
Mean (SD)
Median (IQR)
Total Verbal Utterances*
Mean (SD)
Median (IQR)
Average errors per utterance
Mean (SD)
Median (IQR)
Average utterances per error
Mean (SD)
Median (IQR)
Total words*
Mean (SD)
Median (IQR)
% total words with errors
Mean (SD)
Median (IQR)
Sentence Level Errors*
Mean (SD)
Median (IQR)
Word Level Errors*
Mean (SD)
Median (IQR)
UPMa
Mean (SD)
Median (IQR)
WMPb
Mean (SD)
Median (IQR)
Mean turn length (words)
Mean (SD)
Median (IQR)

Whole Group (n = 53)

Usual Care - Plus (n = 25)

VERSE (n = 28)

307.4 (136.2)
289.0 (220.0)

302.5 (139.6)
292.0 (186.0)

311.8 (135.5)
273.0 (225.0)

228.3 (134.7)
203.0 (155.0)

211.9 (135.7)
202.0 (189.0)

242.9 (134.6)
211.5(194.0)

253.5 (152.1)
215.0 (220.0)

257.3 (144.5)
267.0 (167.0)

250.0 (161.0)
214.5(287.0)

23.3 (45.0)
3.0 (18.0)

17.4
2.0 (17.0)

28.6
6.0 (19.0)

36.3 (50.3)
18.0 (43.0)

22.0 (22.0)
13.0 (36.0)

49.2 (64.0)
24.5 (79.0)

15.2 (16.5)
11.6 (20.6)

12.6 (14.4)
6.9 (16.3)

17.6 (18.1)
13.1 (26.9)

3.2 (1.7)
3.0 (2.8)

2.9 (1.4)
2.8 (1.8)

3.5 (2.1)
3.4 (3.8)

3.6 (2.0)
3.3 (3.1)

3.2 (1.5)
3.1 (2.1)

3.9 (2.3)
3.7 (4.3)

506 (186.6)
510.0 (232.0)

500.8 (206.9)
485.0 (254.0)

510.7 (170.3)
520.5 (257.0)

478.5 (217.0)
495.0 (265.0)

483.4 (225.1)
477.0 (252.0)

474.2 (213.7)
509.0 (317.0)

0.5 (0.2)
0.4 (0.2)

0.4 (0.2)
0.4 (0.2)

0.5 (0.3)
0.4 (0.4)

2.6 (1.3)
2.3 (1.3)

2.8 (1.3)
2.4 (1.3)

2.4 (1.3)
2.3 (1.5)

1689.0 (1313.1)
1443.0 (1552)

1511.6 (1128.2)
1256.0 (1171.0)

1847.4 (1460.7)
1791.5 (2138)

28.3 (41.7)
16.5 (21.5)

22.5 (25.5)
15.4 (19.2)

33.5 (52.1)
18.4 (27.7)

23.9 (30.3)
13.00 (32)

23.4 (34.0)
11.0 (39)

24.3 (27.2)
20.0 (31)

230.0 (160.6)
200 (214)

227.4 (162.3)
249.0 (238)

232.4 (162.0)
182 (202)

9.7 (3.3)
9.3 (4.9)

9.8 (3.6)
9.5 (6.0)

9.7 (3.1)
9.2 (4.0)

32.8 (24.2)
29.5 (28.3)

29.5 (19.8)
29.4 (27.2)

35.7 (27.7)
33.7 (51.5)

5.7 (5.1)
4.0 (7.0)

4.8 (3.5)
4.0 (4.3)

6.5 (6.2)
4.6 (9.3)

Note: * These measures were standardized according to session length. Descriptive statistics are presented in their
raw score to maintain context.
a
Utterances per minute.
b
Words per minute.
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Table 9. Dosage (Therapist Inputs) Descriptive Statistics.
Measure
Cues used with success*
Mean (SD)
Median (IQR)
Total number of cues used*
Mean (SD)
Median (IQR)
% Cues that were successful
Mean (SD)
Median (IQR)
Total therapist utterances*
Mean (SD)
Median (IQR)

Whole Group (n = 53)

Usual Care – Plus (n = 25)

VERSE (n = 28)

33.8 (38.6)
18.0 (50)

38.5 (48.5)
15.0 (70)

29.6 (27.4)
19.5 (49)

81.7 (72.9)
52.0 (110)

86.6 (74.8)
71.0 (112)

77.3 (72.3)
46.0 (110)

39.9 (23.4)
40.4 (31.2)

38.2 (26.9)
33.3 (43.9)

41.5 (20.0)
40.8 (25.2)

675.1 (252.5)
642.0 (403)

679.6 (226.0)
656.0 (309)

671.1 (278.1)
639.5 (472)

Note: *These measures were standardized according to session length. Descriptive statistics are presented in their
raw score to maintain context.
Utterances per minute.
b
Words per minute.
a

(words and morphemes), total words, percentage of total words with errors,
words per minute, mean turn length (words), cues used with success, total
number of cues used and total therapist utterances. Signiﬁcant diﬀerences
between the moderate and severe severity groups were seen in measures of
spontaneous verbal utterances, non-verbal responses, percentage of errors
self-corrected, mean length of utterance (words and morphemes), total verbal
utterances, total words, percentage of total words with errors, utterances per
minute, words per minute, mean turn length (words). The direction of the signiﬁcance can be seen in the means provided. All other variables did not meet
Table 10. Dosage (client acts) descriptive statistics, (mean (SD)) and group comparisons by
aphasia severity.
Measure
Error free utterances*
Errors*
Spontaneous verbal*
Non-verbal responses*
Self-Corrections*
% errors self-corrected
MLU (words)
MLU (morphemes)
Total Verbal Utterances*
Average errors per utterance
Average utterances per error
Total words*
% total words with errors
Sentence level errors*
Word level errors*
UPM
WMP
Mean turn length (words)

Mild (n = 16)

Moderate (n = 17)

Severe (n = 20)

ANOVA p-value

340 (149.4)
223.2 (152.9)
318.6 (139.8)
4.7 (7.3)
68.2 (70.1)
30.8 (18.7)
4.7 (1.4)
5.2 (1.6)
503.9 (1.8)
0.5 (0.4)
3.0 (1.8)
2442.5 (1153.5)
9.6 (6.4)
25.8 (22.7)
223.9 (180.5)
9.8 (3.2)
47.2 (20.0)
9.3 (4.6)

354.3 (125.3)
292.4 (147.0)
329.8 (136.9)
2.8 (3.5)
40.5 (37.4)
14.0 (10.7)
3.5 (1.3)
3.9 (1.5)
604.5 (171.2)
0.5 (0.2)
2.4 (0.9)
2208.1 (1335.1)
15.8 (8.8)
34.4 (43.1)
310.1 (168.3)
11.3 (2.7)
42.0 (24.3)
6.5 (5.0)

241.5 (111.7)
177.8 (81.4)
136.5 (94.3)
55.7 (61.1)
7.4 (11.2)
3.9 (5.6)
1.8 (1.2)
2.0 (1.4)
351.1 (207.6)
0.5 (0.2)
2.4 (1.0)
645.0 (548.4)
53.8 (59.5)
13.5 (18.3)
167.0 (105.1)
8.4 (3.5)
13.4 (12.2)
2.2 (3.1)

.045
.086
.000b,c
.000b,c
.001b
.000a,b,c
.000a,b,c
.000a,b,c
.023c
.988
.242
.000b,c
.001b,c
.158
.057
.023 c
.000b,c
.000b,c

Note: MLU = Mean length of utterance. UMP = Utterances per minute. WPM = Words per minute.
*These measures were standardized according to session length. Descriptive statistics are presented in their raw
score to maintain context.
a
Signiﬁcant diﬀerence between the mild and moderate groups.
b
Signiﬁcant diﬀerence between mild and severe groups.
c
Signiﬁcant diﬀerence between the moderate and severe groups.
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Table 11. Dosage (therapist inputs) descriptive statistics (mean (SD)) comparisons by aphasia
severity.
Measure

Mild (n = 16)

Moderate (n = 17)

Severe (n = 20)

ANOVA p-value

Cues used with success*
Total number of cues used*
% Cues that are successful
Total therapist utterances*

9.6 (8.5)
29.9 (31.6)
38.5 (26.8)
506.1 (188.6)

37.5 (35.7)
91.8 (69.6)
41.9 (22.7)
696.4 (260.6)

50.1 (46.7)
114.5 (78.8)
39.5 (22.1)
792.4 (224.2)

.004a
.001a
.914
.000a

Note: *These measures were standardized according to session length. Descriptive statistics are presented in their
raw score to maintain context.
a
Signiﬁcant diﬀerence between mild and severe groups.

signiﬁcance in post hoc testing p > 0.05. For full statistical sentences of each of
the post hoc analyses please see Appendix C.
Dose – active ingredients
Table 12 shows the linear regression of within session dosage measures and the
WABR-AQ score at 12 weeks post stroke. A Bonferroni correction was set for multiple comparisons (0.05 / 18 measures) at p < 0.00277 and no measures met these
criteria for 12 weeks post stroke. Measures that were signiﬁcantly predictive with
the WABR-AQ score at 26 weeks post stroke, as per Table 13 were: total verbal
utterances, percentage of total words with errors and the number of cues
used with success. These were hypothesized as key therapeutic ingredients in
the treatment and used in the cumulative intervention intensity calculation.
Table 12. Linear regression of dose (client acts and therapist inputs) with patient outcome at 12
weeks post stroke.
Unstandardized
Measure

Beta
(B)

Standard error for
Beta (SE B)

Standardized
Standardized Beta
(β)

Total error free
1.947
0.911
.194
utterances*
Total Errors*
0.815
0.97
0.077
Spontaneous verbal
2.133
0.953
0.232
utterances*
Self-corrections*
0.744
2.716
0.028
% Errors self-corrected
0.108
0.198
0.069
MLU (words)
1.94
1.901
0.134
Total Turns taken*
1.437
0.664
0.191
Total Verbal Utterances*
1.502
5.72
0.235
Average errors per
−6.23
9.514
0.060
utterance
−1.609
1.84
−0.081
Average utterances per
error
Total words*
0.164
0.126
0.150
Sentence level errors*
4.153
4.216
0.090
Word level errors*
0.708
0.763
0.085
% Total words with
−0.139
0.062
−0.231
errors
Utterances per minute
1.455
0.668
0.192
Words per minute
0.167
0.121
0.157
Mean Turn Length
0.576
0.572
0.115
Cues used with success*
7.274
3.115
0.219
Note: * denotes variables were adjusted for length of session time.

t-test
statistic (t)

Probability
(p)

2.138

0.038

0.84
2.238

0.405
0.030

0.274
0.546
1.021
2.165
2.627
−0.655

0.785
0.588
0.313
0.036
0.012
0.516

−0.874

0.386

1.305
0.985
0.928
−2.22

0.198
0.33
0.358
0.031

2.179
1.387
1.007
2.335

0.034
0.172
0.319
0.024
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Table 13. Linear regression of dose (client acts and therapist inputs) with patient outcome at 26
weeks post stroke.
Measure

B

SE B

Total error free utterances*
2.332
0.934
Total Errors*
1.603
0.962
Spontaneous verbal utterances*
2.334
0.994
Self-Corrections*
1.006
2.809
% Errors self-corrected
0.053
0.205
MLU (words)
2.534
1.961
Total Turns taken*
1.937
0.687
Total Verbal Utterances*
2.077
0.577
Average errors per utterance
−2.989
−0.031
Average utterances per error
−3.075
1.874
Total words*
0.213
0.13
Sentence level errors*
5.024
4.381
Word level errors*
1.31
0.783
% Total words with errors
−0.21
0.06
Utterances per minute
1.961
0.691
Words per minute
0.213
0.125
Mean Turn Length
0.637
0.592
Cues used with success*
10.82
3.039
Note: *denotes variables were adjusted for length of session time.
a
denotes signiﬁcance after Bonferroni correction at p < 0.00277.

β

t

p

0.249
0.166
0.268
0.042
0.037
0.188
0.268
0.337
−0.031
−0.170
0.205
0.118
0.168
−0.381
0.270
0.212
0.137
0.355

2.498
1.666
2.347
0.358
0.26
1.292
2.82
3.598
−0.301
−1.641
1.637
1.147
1.673
−3.479
2.837
1.707
1.076
3.561

0.016
0.103
0.023
0.722
0.796
0.203
0.007
0.001a
0.765
0.108
0.109
0.258
0.101
0.001a
0.007
0.095
0.288
0.001a

Cumulative intervention intensity
The dosage measures that were predictive of WABR-AQ score at 26 weeks
post stroke were considered to be key therapeutic ingredients for this treatment and population. Measures that were predictive of patient response at
26 weeks post stroke were total verbal utterances, percentage of total
words with errors and cues used with success. Speciﬁcally the greater the
number of total verbal utterances that were produced per session (irrespective
of errors), the better the WABR-AQ score was at 26 weeks. The percentage of
total words with errors in the session was negatively associated with WABRAQ score meaning that the lower the percentage of words with errors in
the session, the higher the WABR-AQ score. Cues used with success was positively associated, with WABR-AQ at 26 weeks post stroke. The percentage of
total words with errors measure was a percentage calculation [(errors) /
(total words) × 100] and so the mean value is not representative of the
number of times the ingredient occurred during the session rather a
percentage of two other measures. As such it was problematic to use in
the intensity calculation and not selected. Therefore, total verbal utterances
and cues used with success were selected as the key therapeutic ingredients
in these treatments to use in the calculation of cumulative intervention
intensity.
Figure 4 presents the cumulative intervention intensity for both therapy
groups as per the sample used in this analysis. This ﬁgure is adapted from
Baker (2012) which was based on Warren et al. (2007) dosage concepts. When
considering the number of verbal utterances produced and the number of
cues used with success per session, people in the Usual Care-Plus group
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Figure 4. Calculation of cumulative intervention intensity as per Warren et al. (2007) concepts.
Numbers presented in parentheses are the mean values from the sample.

averaged 522 active ingredient episodes each session with ﬁve sessions/ week
taking place over four weeks. This resulted in an average cumulative intervention
intensity of 10,400 during the trial. For individuals in the VERSE arm of the trial an
average of 504 active ingredient episodes occurred each session over ﬁve sessions/ week for four weeks to give a cumulative intervention intensity of
10,080 during the trial.
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Discussion
This study aimed to provide insight into the dosage level provided within the
intensive intervention arms of the VERSE trial (Godecke et al., 2016). Speciﬁcally,
we have provided (i) normative dosage data across the intervention groups and
aphasia severities; (ii) an exploration of potential key therapeutic ingredients to
explain recovery in this population; and (iii) a speciﬁcation of the intervention
according to the dosage and intensity theory of Warren et al. (2007). Our goal
was not to provide a therapy regimen for therapists to follow. Rather, we
aimed to develop an increased understanding of the key ingredients of the
therapy provided in the VERSE trial and the dosage with which theorized ingredients were provided. In doing so we have trialled a method of identifying
potential active ingredients and measuring dosage for this population. We
hope to stimulate further discussion and encourage the research agenda in
the area in order to improve the methodology used within intervention
studies when considering the way in which therapies are delivered. In the
long term this will assist in uncovering the elements of treatment that are
most likely to improve functional outcomes and the dosage with which these
elements, or ingredients, are delivered.

The therapy black box
On average, the participants within this study, who were from three aphasia
severity groups, made a clinically signiﬁcant improvement in their recovery
from aphasia as measured by the WABR-AQ (Kertesz, 2006). Turkstra et al.
(2016) proposed that any treatment be speciﬁed using three elements of treatment theory: (i) targets, (ii) ingredients and (iii) mechanisms of action. These
elements of treatment theory are likely to make up the as yet unknown “black
box” of aphasia interventions (DeJong et al., 2005; Walker et al., 2017). The
main contribution of these results is to the ingredients element of treatment
theory (Turkstra et al., 2016). Whilst no single piece of research can establish
what, how and how much to do in therapy, we trialled a method of identifying
key ingredients for therapy provided within the VERSE trial and measured the
dosage with which signiﬁcant ingredients occurred. Within this study three
measures were identiﬁed that were associated with language outcome at 26
weeks post stroke. These were increased verbal utterances (client act),
reduced percentage of words produced which contained errors (client act)
and increased cues used with success (likely represents both a client act and
therapeutic input). Interestingly these measures represented both therapeutic
inputs and client acts (Kleim & Jones, 2008) in Baker’s (2012) model and may
be the evidence based kernels or the active ingredients of the treatment
within this intervention trial (Embry & Biglan, 2008). While the model shown in
Figure 5 is focused on the teaching episodes within tasks it is acknowledged
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Figure 5. Adapted from Baker (2012), the relationship between dose form, teaching episodes
and active ingredients.

that there are many other components of the rehabilitation jigsaw that contribute to therapeutic success, in conjunction with the teaching episode, and a few
are listed here.
The results presented here support an error minimization (not error-free)
approach possible through a targeted cueing programme that aims to create successful verbal production. This is balanced with encouraging the person with
aphasia to say as much as possible and to provide clinical support to facilitate production which contains as few errors as possible. It should be highlighted that
intervention provided in the VERSE trial was provided during early aphasia recovery and so it is unknown if these ﬁndings would be similar for people in the chronic
phase of recovery. Within this study a novel approach was used to determine key
therapeutic ingredients of the treatment in an attempt to explore how therapeutic
ingredients may be identiﬁed. A regression model was used with the WABR-AQ as
the dependent variable and while this approach found predictions with three
dosage measures, caution is needed with interpretation. Measures that were predictive (speciﬁcally verbal utterances and reduced percentage of words with
errors) may logically be related to the WABR-AQ score. That is, a person with
aphasia who produces more utterances and less errors will have a better score
on the WABR which is by design a predominantly verbal accuracy test.
However, of note, is that the measures were taken within the ﬁrst month post
stroke, and were predictive at six months and baseline aphasia severity and
amount of intervention received was included in the model. This has provided
an attempt at identifying how the handling of errors, or other potential key ingredients such as cueing, aﬀected target attainment more generally (Turkstra et al.,
2016). This predictive relationship was observed from a snapshot of therapy sessions that involved sixty nine diﬀerent therapy tasks in early aphasia recovery.
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This ﬁgure is adapted from Baker (2012) and explores the relationship
between key components of dosage and speech language pathology interventions. The puzzle piece represents other elements of rehabilitation that may contribute to therapeutic success.
Literature outlining complex treatments often lack information regarding
speciﬁc active ingredients and their corresponding dosage. This is largely due
to diﬃculty investigating these complex behavioural interventions and the
impact of a myriad of factors including therapeutic relationship, environment
and client motivation (Cherney, 2012). We used a formula presented by
Warren et al. (2007) to calculate the dosage and cumulative intervention intensity for a sample of therapy delivered in the VERSE trial. Identifying the key therapeutic ingredients was challenging especially as tasks were not controlled and
retrospective data were used. Potential ingredients were identiﬁed in the
design phase that linked to the theory underpinning the interventions. That is,
the measurement and handling of errors was thought to be key to neurorehabilitative learning and aphasia therapy and so prioritized. Then in an exploratory
manner these key ingredients were counted and coded in the analysis phase
however we acknowledge that the active ingredients measured here do not represent all possible key ingredients. The level of analysis undertaken in this study
was time consuming however it provides a framework for this line of inquiry to
develop further. We suggest focusing on the theory behind the intervention to
measure targeted ingredients only in a prospective manner. That is, measure a
small number of ingredients thoroughly with the aim to draw conclusions
about their role in therapy, whilst embedding a larger rigorous ﬁdelity monitoring process to establish treatment adherence and diﬀerentiation. The detailed
analysis of active ingredients should be included in all smaller pilot studies
with an aim to discover which ingredients are positively associated with
outcome. These intervention kernels should then be tested on a larger sample
in feasibility and Phase-III studies.
Critical variables for aphasia therapy are thought to include the intensity and
dosage, therapeutic relationship, medium of therapy delivery, client motivation
to engage, cognitive ability and neurological stability (Whitworth et al., 2014) and
the active ingredients that promote an individual’s recovery may lie within these
variables. There is also the possibility that the active ingredients of therapy are
not directly observable or so readily measurable. The concept of activity challenge and the level of task diﬃculty is a parameter in stroke rehabilitation that
is receiving increasing attention and will inﬂuence the outcome of future
study designs (Akizuki & Ohashi, 2015; Woodbury et al., 2016). Therefore, not
only should the quantity of therapeutic inputs and client acts be addressed
but also the quality of these, such as a measure of task diﬃculty relative to
the individual, with an optimal challenge point identiﬁed (Guadagnoli & Lee,
2004). An alternative but related view of therapy could be gained through qualitative analysis and/or systemic function linguistic analysis (O’Halloran, 2004) of
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therapy videos. This could investigate more thoroughly aspects of the therapeutic relationship such as rapport and patient comfort levels. It is acknowledged that an in-depth analysis was not completed to explore the nature of
interactions between the therapists and people with aphasia. This was not the
aim of the work, however such an undertaking is likely to capture a richness
of therapy not represented in the quantitative data set.
Dosage
The optimal treatment dosage in aphasia rehabilitation is unknown with signiﬁcantly more research required (Baker, 2012; Dignam et al., 2015; Oﬀ et al., 2016).
For this study the cumulative intervention intensity is over 10,000 occurrences of
the ingredients predictive of recovery within an intervention block of twenty sessions. This means that, on average, approximately 500 of these key ingredients
were delivered and received each session. The VERSE trial’s primary hypothesis
investigated an intensive therapy schedule which demonstrated equivalent outcomes between intensive therapy and standard care in early stroke recovery
(Godecke et al., 2018). It should be highlighted that only data from the intensive
intervention arms of the trial were included in this study, videos from therapy
provided within non intensive usual care were not included and so we don’t
know the ﬁndings from therapy that may be delivered at a lower dose. It may
be that the within session dosage level that was delivered is necessary but not
on an intensive schedule. In the overall trial cohort sessions of longer duration
were associated with better recovery than a larger number of shorter sessions
(Rai et al., 2019). Sessions of longer duration may result in an increased
dosage of the key client acts and therapist inputs. Based on VERSE eﬃcacy
data, positive therapeutic results may be achieved with less frequent sessions
but this level of within session dosage. Alternatively, it may be that the
dosage level provided in the VERSE trial is not necessary and participants were
“overdosed”. A further alternative is that the dosage provided to the participants
in the VERSE trial, and in this study, was insuﬃcient to show beneﬁt in communication and language. Harnish et al. (2014) measured the dosage of active ingredients in a cueing treatment for people with chronic aphasia and found positive
outcomes with 400 attempts per session for a total of 3200 teaching episodes.
Therefore, future studies may aim to determine a threshold at which these
potential active ingredients are associated with a positive outcome within a
session in order to inform research consumers about what was delivered in
the trial and assist research translation.
This study outlines the ﬁndings of a detailed analysis of the intervention
dosage provided within the VERSE study however, while the length of the sessions was set, a minimum target for repetitions was not set in either the prescribed or Usual Care-Plus conditions. We have provided an analysis of a
“typical” 45–60 min aphasia therapy session using usual care data, possibly
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providing a benchmark to be used as normative data in the future. Usual CarePlus therapists were not given a prescribed therapy. Therefore, we believe that
the results presented here are representative of therapy provision within Australia and the dosage level seen within a sessions of this length. This, combined with
the information from the main trial (usual care was two to three times per week
for 30–36 min or 9.5 h of direct aphasia therapy within the ﬁrst 50 days post
stroke), provides an unprecedented level of information on usual care aphasia
therapy within Australia and New Zealand. It is interesting to note that there
was not treatment diﬀerentiation for dosage between the prescribed intervention (VERSE) and Usual Care-Plus on the analyses completed as part of the
current study. And so, even when a treatment was prescribed to the therapists,
the measures examined in this study did not diﬀer signiﬁcantly. This may be
because Usual Care-Plus therapists were using the same principles as the prescribed therapy, or that there is a homogeneity in the way that PWA respond
to tasks.
There were statistically signiﬁcant diﬀerences in the measured dosage variables across aphasia severities as expected. This demonstrated that classiﬁcation
of severity at baseline remained relevant to the performance of PWA during
therapy sessions within the subsequent month. Of note, people with severe
aphasia had signiﬁcantly less spontaneous verbal utterances, percentage of
errors self-corrected and words spoken compared to people with mild and moderate aphasia. They were consistently lower on verbal eﬃciency measures such
as utterances per minute, words per minute and mean length of utterance. As
this ﬁts the common picture of aphasia severity it may also be expected that
they would make more mistakes in a session. People with moderate aphasia produced the most errors (total errors) but also more utterances without errors and
more total verbal utterances than people with severe aphasia. This may reﬂect a
trade-oﬀ of attempting to say more but making more errors in the process. As a
proportion of the total words produced people with severe aphasia made errors
over 50% of the time. This was consistent even in the prescribed VERSE condition
that aimed for an error free approach. Even when aiming for an errorless or error
minimization learning approach with someone with severe aphasia, therapists
may not be able to restrict errors to less than 50% of words produced. It is possible that regardless of the therapists’ attempts to limit errors, there is a predictability and a homogeneity to the way PWA respond in a task. People with mild
aphasia produced more self-corrections and were able to produce more words
across less utterances reﬂected in a higher MLU. As expected, many of the participants with mild aphasia at baseline approached ceiling level on the WAB-AQ
by 12 and 26 weeks post stroke.
These ﬁndings encourage researchers to undertake ﬁne-grained dosage
(number of therapeutic inputs and client acts) analyses of their research in
both intervention and control groups. The analyses completed here demonstrate
that this is feasible within a portion of the RCT cohort. By nature, retrospective
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analysis of a cohort such as completed here is unable to systematically identify
and vary dosage variables. Prospective hypothesis driven studies that manipulate ingredients and dose may facilitate a clearer interpretation. The ingredients
identiﬁed in this study would beneﬁt from planned experimental investigations
to test the robustness of the interpretations. Dose escalation study designs are
being adapted for rehabilitation research and present one possible future direction for aphasia (Kramer et al., 2018). Additionally, future research would beneﬁt
from focusing on conceptualizing dosage in terms of number of key ingredients
(therapeutic inputs and client acts), rather than time spent in therapy, to progress the evidence base. Research needs to document dosage in this way for
treatments given in trials, however speciﬁc research in which dosage is varied
within a treatment is also needed (Kramer et al., 2018). It would be of value
for RCT pilot studies to conceptualize potential active ingredients in the trial
design phase, measure these against outcomes, ﬁne tune the procedure and
then scale up to the larger trial.
Clinical signiﬁcance
Investigating dosage in aphasia research is important in the clinical realm. An
inaccurate dose may be a waste of precious resources, harmful, ineﬀective or
equivalent to no intervention (Baker, 2012). Treatments are implemented in practice that combine several diﬀerent forms and doses of intervention and typically
this combination is untested and the implementation may be in direct contrast
to how they were evaluated (O’Hare & Doell, 2015; Waller, 2009). These are called
“third wave therapies” and they may not provide the required dosage of therapy
to be eﬀective (Waller, 2009). In addition, the dosage level decided on by a therapist may be inﬂuenced by all areas of the evidence based practice triad, including
patient values and clinical expertise (Sackett et al., 1996). If researchers can
provide clinicians with the evidence of a threshold dose for a treatment then
therapists can more accurately manipulate treatments according to clinical
results and patient related factors. If a speciﬁc dose can be determined then services can be utilized at their optimum level and resources can be reallocated
where necessary.
Limitations
This study aimed to explore dosage, as provided in the VERSE study, and trialled
a method for analysing the therapy provided. It was a novel approach and
although the ﬁndings give an important insight into therapeutic dosage, the
method for identifying key ingredients should be interpreted with caution. A
reductive interpretation of the methodology used in this study would be that
measures that were predictive of outcome may logically be related to the
WABR-AQ score. That is, a person with aphasia who produces more utterances
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and less errors in therapy will have a better score on the WABR-AQ which is by
design a predominantly verbal accuracy test. The study was retrospective and
therefore dosage variables at the ingredients level were not able to be controlled
or manipulated. This study design adds complexity to the relationship interpretation. The values used in the cumulative intervention intensity model are
averages attained in the analysis. The drawbacks of using average scores as a
measure is acknowledged. The WAB-R is predominantly a verbal accuracy test.
Other modalities for the outcome measure such as written expression or receptive language were not considered in the scope of this work. This study analysed
12% of the available videos in the VERSE trial. This represents a small sample and
so there is a limit to the extrapolation of these results to represent the dosage
within the trial as a whole. Additionally this means the current study may have
been underpowered. The primary rater for the videos was not blinded to the
treatment condition as unblinding was necessary for monitoring protocol adherence and treatments were also easily distinguishable based on task selection and
the potential for bias exists.

Conclusion
This study demonstrated it is feasible to analyse the dosage of therapy in aphasia
rehabilitation. Overall, these results suggest that an error minimization but verbal
maximization strategy using a targeted cueing programme is beneﬁcial for
people with aphasia in the early stroke recovery period. There is, of course,
great diﬃculty in determining what our therapy consists of and the way in
which this acts on the brain to facilitate recovery. Regardless of the intensity
regimen, we have demonstrated that this cumulative intervention intensity
and within session level dosage contributes to positive outcomes for people
with aphasia in early stroke recovery.
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Appendices
Appendix A. Tasks completed in usual care-plus condition
Type of Task, in order of most to least frequent (n = 51)
Expressive Language – Verbal
Single Word Level
Picture Naming
Semantic association naming
Automatic Speech
Odd one out (semantic)
Naming minimal Pairs
Object naming
Question and Answer task

Quantity (n = 96)

12
5
4
3
2
2
2
(Continued)
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Continued.
Type of Task, in order of most to least frequent (n = 51)
Selecting prepositions
Generating synonyms
Generating antonyms
Convergent naming
Repetition of non-words
Phonemic Generative Naming
Semantic Category identiﬁcation
Single word repetition
Sentence Level
Picture description (not personal photo)
Constraint Induced Aphasia Therapy (CIAT) style barrier game
Reading aloud
Verbal reasoning (idioms and problem solving)
Articulate game (verbal explanation)
Personal photo description
Procedural discourse (e.g., making a cup of tea)
Reading semantic feature analysis prompts for to generate words
Script training
Solitaire card game (verbal requests)
Taboo (verbal explanation)
Conversation Level
Conversation
Situational Language (e.g., ordering a coﬀee)
Expressive Language – Written
Single Word Level
List writing (self-generated words)
Single word writing (from dictation)
Crosswords
Functional writing (name, address etc.)
Hangman game (letter and word generation)
Sentence Level
Written work sheet for sentence composition
Writing answers to reading comprehension
Written picture description
Receptive – Reading Comprehension
Paragraph Comprehension (answering questions)
Receptive – Auditory Comprehension
Single Word Level
Object to picture matching
Picture matching (same picture to same picture)
Semantic association receptive task (match associated pictures)
Semantic association (which one can you eat?)
Single word auditory comprehension
Sentence Level
Semantic description comprehension task
Following a receptive command to place a picture in a grid
Paragraph level
Newspaper article with multiple choice questions
Paragraph comprehension (listening for the main idea)
Yes/No Questions after listening to a paragraph
Other – iPad Tasks
iPad written single word to picture matching
iPad articulation app
iPad choosing the missing letter
iPad sorting jumbled letters
iPad verbal single word to picture matching

Quantity (n = 96)
2
2
1
1
1
1
1
1
5
3
3
2
1
1
1
1
1
1
1
4
1
2
2
1
1
1
2
1
1
2
2
1
1
1
1
2
1
1
1
1
2
1
1
1
1
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Appendix B. Tasks completed in VERSE condition
Type of Task (n = 18)
Expressive Language – Verbal
Single Word Level
Picture Naming
Memory Game with naming
Snap Game with naming
Automatic Speech
Sentence Level
Picture description
Opinion giving
Verbal reasoning
Procedural discourse
Sequence picture cards and asked to tell the story
Question and Answer
Spot the diﬀerence
Verb generation sentence level
Using three words to make a sentence
Reading aloud
Conversation Level
Conversation
Receptive – Reading Comprehension
Paragraph Comprehension
Receptive – Auditory Comprehension
Single Word Level
Point to the picture multiple choice
Above Single Word Level
Sentence Comprehension

Quantity (n = 56)

10
1
1
1
8
1
1
2
4
2
1
1
1
2
12
3
4
1

Appendix C
The eﬀect of severity on spontaneous verbal utterances was signiﬁcant F (2,50) = 13.87, p =
000. Post hoc analyses indicated that the number of spontaneous verbal utterances was signiﬁcantly higher in the mild to severe (p = 0.000) and moderate to severe (p = 0.000) groups.
The eﬀect of severity on non-verbal utterances was signiﬁcant F (2,50) = 11.541, p = 000 and
signiﬁcantly higher in the severe compared to mild group (p = 0.001) and the moderate to
severe (p = 0.000) group. The number of self-corrections was signiﬁcantly aﬀected by
aphasia severity F (2,50) = 8.762, p = 001. Post hoc analysis indicated that the number of
self-corrections was signiﬁcantly greater in the mild compared to severe group (p = 0.000).
Percent of errors self-corrected was signiﬁcantly aﬀected by aphasia severity F (2,50) =
21.137, p = 000. Post hoc analyses indicated that the mild group had a signiﬁcantly higher percentage of self-corrections compared to the moderate (p = 0.001) and severe groups (p =
0.000) and the moderate group had a signiﬁcantly higher percentage of self-corrections compared to the severe group (p = 0.050). The eﬀect of aphasia severity on mean length of utterance (words) was signiﬁcant F (2,50) = 22.619, p = 000. Post hoc analyses indicated that the
mild group had a signiﬁcantly higher mean length of utterance compared to the moderate
(p = 0.034) and severe groups (p = 0.000) and the moderate group had a signiﬁcantly
higher mean length of utterance compared to the severe group (p = 0.001). The eﬀect of
aphasia severity on mean length of utterance (morphemes) was signiﬁcant F (2,50) =
21.649, p = 000. Post hoc analyses after Bonferroni correction indicated that the mild group
had a signiﬁcantly higher mean length of utterances (morphemes) compared to the moderate
(p = 0.043) and severe groups (p = 0.000) and the moderate group had a signiﬁcantly higher
mean length of utterance (morphemes) compared to the severe group (p = 0.001). Aphasia
severity signiﬁcantly aﬀected the number of total utterances in a session F (2,50) = 4.051, p
= .023. In post hoc analysis the severe group had signiﬁcantly fewer total utterances than
the moderate severity group (p = 0.019). Aphasia severity signiﬁcantly aﬀected the number
of total words in a session F (2,50) = 17.695, p = .000. Post hoc analyses demonstrated that

NEUROPSYCHOLOGICAL REHABILITATION

35

the number of total words in a session was signiﬁcantly higher in the mild group compared to
the severe group (p = 0.000). And the moderate severity group said signiﬁcantly more words
than the severe group (p = 0.000). Aphasia severity signiﬁcantly aﬀected the percent of total
words that had errors F (2,50) = 7.689, p = .001. Post hoc analyses indicated that the number of
total words with errors was signiﬁcantly lower in the mild group compared to the severe group
(p = 0.003). And the moderate severity group had signiﬁcantly less percentage of total words
with errors compared to the severe group (p = 0.010). The eﬀect of aphasia severity on utterances per minute was signiﬁcant F (2,50) = 4.053, p = 023 with the moderate severity group
having a signiﬁcantly higher utterance per minute ratio than the severe group (p = 0.019).
The eﬀect of aphasia severity on words per minute was signiﬁcant F (2,50) = 16.825, p =
000. Post hoc analyses revealed that the mild severity group and the moderate severity
group had a signiﬁcantly higher words per minute ratio compared to the severe group, (p
= 0.000) and (p=0.000) respectively. The eﬀect of aphasia severity on mean turn length
(words) was signiﬁcant F (2,50) = 12.063, p = 000. Post hoc analyses indicated that the mild
severity group and the moderate severity group had a signiﬁcantly higher mean turn
length compared to the severe group (p = 0.000) and (p=0.008) respectively. Aphasia severity
signiﬁcantly aﬀected the number of cues used successfully in a session F (2,50) = 6.137, p
= .004, as signiﬁcantly less cues were used with success in the mild compared to severe severity groups (p = 0.003). Aphasia severity signiﬁcantly aﬀected the number of total cues used F
(2,50) = 7.660, p = .001. Post hoc analyses indicated that signiﬁcantly less cues were used in
total in the mild compared to severe severity groups (p = 0.001). The eﬀect of aphasia severity
on the total utterances used by the therapist was signiﬁcant F (2,50) = 11.086, p = 000. In a post
hoc analysis there were signiﬁcantly less utterances by the therapist in the mild compared to
severe group (p = 0.000).
All other variables did not meet signiﬁcance in post hoc testing p > 0.05.

